Erlizumab is a humanized monoclonal antibody designed to target Integrin beta-2 (ITGB2 / CD18), offering therapeutic potential in the management of hemorrhagic shock. This antibody selectively binds to Integrin ??2, a protein involved in leukocyte adhesion and migration, thereby modulating inflammatory responses critical in the pathology of hemorrhagic shock. Erlizumab provides a novel approach to modulate the immune system's response under these critical conditions.
Erlizumab is a humanized monoclonal antibody designed to target Integrin beta-2 (ITGB2 / CD18), offering therapeutic potential in the management of hemorrhagic shock. This antibody selectively binds to Integrin ??2, a protein involved in leukocyte adhesion and migration, thereby modulating inflammatory responses critical in the pathology of hemorrhagic shock. Erlizumab provides a novel approach to modulate the immune system's response under these critical conditions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
